CR8174A - Composicion parasiticida - Google Patents
Composicion parasiticidaInfo
- Publication number
- CR8174A CR8174A CR8174A CR8174A CR8174A CR 8174 A CR8174 A CR 8174A CR 8174 A CR8174 A CR 8174A CR 8174 A CR8174 A CR 8174A CR 8174 A CR8174 A CR 8174A
- Authority
- CR
- Costa Rica
- Prior art keywords
- closantel
- bioavailability
- parasiticiated
- composition
- salicylanide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
- A01N37/38—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system
- A01N37/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system having at least one carboxylic group or a thio analogue, or a derivative thereof, and one oxygen or sulfur atom attached to the same aromatic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/609—Amides, e.g. salicylamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Agronomy & Crop Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pest Control & Pesticides (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Toxicology (AREA)
- Road Paving Structures (AREA)
Abstract
Una composicion parasiticida presentada como un producto topico para verter sobre el animal ("puor-on") para tratar animales infestados por parasitos que son susceptibles a las salicilanilidas, especialmente a closantel, solo o junto con por lo menos otro compuesto antiparasitario del tipo de avermectina o milbemicina y que ofrece mayor biodisponibilidad de la salicilanida, mediante la provision de un sistema de suministro que comprenden por lo menos 20% (v/v) de uno o mas alcoholes, y que incluye opcionalmente una parte polimerica seleccionada entre el grupo que consiste en polivinilpirrolidona (PVP), copolimeros de bloques de polioxipropileno/ polioxietileno (poloxamero) y polietilenglicoles (PEG), mejorando de este modo la biodisponibilidad, por ej., de closantel.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0316377.1A GB0316377D0 (en) | 2003-07-12 | 2003-07-12 | Parasiticidal composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CR8174A true CR8174A (es) | 2006-10-05 |
Family
ID=27742085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR8174A CR8174A (es) | 2003-07-12 | 2006-01-05 | Composicion parasiticida |
Country Status (29)
Country | Link |
---|---|
US (1) | US8993546B2 (es) |
EP (2) | EP2286876A1 (es) |
JP (1) | JP4677405B2 (es) |
KR (1) | KR101095419B1 (es) |
CN (1) | CN1822880B (es) |
AP (1) | AP2956A (es) |
AU (1) | AU2004257450B2 (es) |
BR (1) | BRPI0412522A (es) |
CA (1) | CA2532199C (es) |
CR (1) | CR8174A (es) |
DK (1) | DK1646425T3 (es) |
EA (1) | EA009602B1 (es) |
EC (1) | ECSP066360A (es) |
ES (1) | ES2390224T3 (es) |
GB (2) | GB0316377D0 (es) |
GE (1) | GEP20094648B (es) |
HK (1) | HK1096621A1 (es) |
HR (1) | HRP20120721T1 (es) |
IL (1) | IL173057A (es) |
MX (1) | MXPA06000135A (es) |
NO (1) | NO336181B1 (es) |
NZ (1) | NZ544973A (es) |
OA (1) | OA13188A (es) |
PL (1) | PL1646425T3 (es) |
PT (1) | PT1646425E (es) |
SI (1) | SI1646425T1 (es) |
TN (1) | TNSN06006A1 (es) |
WO (1) | WO2005007241A1 (es) |
ZA (1) | ZA200600374B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002952597A0 (en) * | 2002-11-11 | 2002-11-28 | Schering-Plough Pty. Limited | Topical parasiticide formulations and methods of treatment |
GB0501220D0 (en) * | 2005-01-21 | 2005-03-02 | Norbrook Lab Ltd | Anthelmintic composition |
GB0711957D0 (en) * | 2007-06-21 | 2007-08-01 | Syntopix Ltd | Formulations |
CN101693009B (zh) * | 2009-10-27 | 2010-12-01 | 纽素乐必佳(天津)药业集团有限公司 | 牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液及其制备方法 |
FR2991173B1 (fr) | 2012-06-04 | 2015-11-06 | Virbac | Composition veterinaire a administration cutanee a base d'oxyclozanide |
CN103720652B (zh) * | 2014-01-07 | 2016-09-28 | 王玉万 | 用泊洛沙姆和油性介质制备含阿维菌素类药物注射剂 |
WO2019054967A2 (en) * | 2017-03-15 | 2019-03-21 | Verano Ilac Sanayi Ve Ticaret Anonim Sirketi | VETERINARY COMPOSITION TO BE POURED COMPRISING EPRINOMECTIN |
GB201715122D0 (en) * | 2017-09-19 | 2017-11-01 | Omnipharm Dev Ltd | Topical anti-infective formulation |
BR112021006821A2 (pt) * | 2018-10-12 | 2021-07-13 | Hovione Scientia Limited | método de tratamento de inflamação e patologias oftálmicas, dispersão sólida, formulação farmacêutica, método de matar ácaros e kit |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2731386A (en) * | 1951-09-06 | 1956-01-17 | Wallace & Tiernan Company Inc | Antifungal composition |
US3798258A (en) * | 1970-03-13 | 1974-03-19 | Merck & Co Inc | Salicylanilides |
LU62350A1 (es) * | 1970-12-31 | 1972-08-23 | ||
US3950360A (en) | 1972-06-08 | 1976-04-13 | Sankyo Company Limited | Antibiotic substances |
US4005218A (en) | 1975-03-18 | 1977-01-25 | Janssen Pharmaceutica N.V. | Antiparasitic salicylanilide derivatives |
SE434277B (sv) | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
US4201861A (en) | 1977-10-03 | 1980-05-06 | Merck & Co., Inc. | Acyl derivatives of C-076 compounds |
US4206205A (en) | 1977-10-03 | 1980-06-03 | Merck & Co., Inc. | Monosaccharide and aglycone derivatives of C-076 |
US4199569A (en) | 1977-10-03 | 1980-04-22 | Merck & Co., Inc. | Selective hydrogenation products of C-076 compounds and derivatives thereof |
US4171314A (en) | 1977-12-19 | 1979-10-16 | Merck & Co., Inc. | 13-Halo and 13-deoxy C-076 compounds |
US4173571A (en) | 1977-12-19 | 1979-11-06 | Merck & Co., Inc. | 13-Halo and 13-deoxy derivatives of C-076 compounds |
NZ197796A (en) | 1980-08-04 | 1984-11-09 | Merck & Co Inc | Stabilised aqueous formulations containing ivermectin |
NZ210505A (en) | 1983-12-22 | 1988-06-30 | Merck & Co Inc | Parasiticidal compositions containing avermectin or milbemycin derivatives |
NZ335166A (en) | 1999-04-14 | 2001-11-30 | Ashmont Holdings Ltd | Anthelmintic composition containing triclabendazole in at least one solvent |
RU2033150C1 (ru) | 1992-06-10 | 1995-04-20 | Виктор Антонович Дриняев | Препарат для лечения и профилактики псороптоза у животных "аверсект" |
PL174488B1 (pl) * | 1993-05-10 | 1998-08-31 | Merck & Co Inc | Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt |
WO1994027598A1 (en) * | 1993-05-26 | 1994-12-08 | Commonwealth Scientific And Industrial Research Organisation | Antiparasitic compositions |
NZ267366A (en) | 1993-06-15 | 1996-12-20 | Univ Australian | Controlling fasciola and other helminths using a synergistic composition of at least two anthelmintic active drugs each being selected from a different class of drug |
NZ248486A (en) * | 1993-08-24 | 1996-07-26 | Ashmont Holdings Limited Subst | Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent |
FR2739778B1 (fr) * | 1995-10-13 | 1997-12-12 | Virbac Lab | Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal |
RU2112508C1 (ru) | 1995-12-26 | 1998-06-10 | Писков Вячеслав Борисович | Способ лечения и профилактики саркоптоидозов животных |
RU2121831C1 (ru) | 1997-08-01 | 1998-11-20 | Анатолий Александрович Непоклонов | Препарат для профилактики и лечения гиподерматоза крупного рогатого скота |
AUPP105497A0 (en) * | 1997-12-19 | 1998-01-15 | Schering-Plough Animal Health Limited | Aqueous insecticidal pour-on treatment |
RU2129430C1 (ru) | 1998-03-17 | 1999-04-27 | Общество С Ограниченной Ответственностью "Вик - Здоровье Животных" | Препарат для борьбы с экто- и эндопаразитами животных "сантомектин" |
US6239119B1 (en) * | 1998-04-27 | 2001-05-29 | Medimmune Oncology, Inc. | Topical administration of amifostine and related compounds |
GB9816132D0 (en) * | 1998-07-24 | 1998-09-23 | Norbrook Lab Ltd | Non-aqueous anthelmintic composition |
GEP20012490B (en) | 1999-10-21 | 2001-07-25 | Robizon Bostashvili | Means Against Demodicosis of Agricultural and Domestic Animals |
US6340672B1 (en) * | 2000-02-16 | 2002-01-22 | Phoenix Scientific, Inc. | Parasiticidal formulation and a method of making this formulation |
US6399651B1 (en) * | 2000-06-29 | 2002-06-04 | L. Dean Parks | Method of treating dermatoses using avermectin compound |
AUPQ875700A0 (en) * | 2000-07-13 | 2000-08-03 | Reflex Research Limited | Combination compositions |
US7238680B2 (en) * | 2001-06-01 | 2007-07-03 | Rosen Steven E | Topical compositions for veterinary uses |
GB2386067A (en) * | 2002-02-28 | 2003-09-10 | Norbrook Lab Ltd | Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species |
AU2003275779B2 (en) * | 2002-11-11 | 2009-02-05 | Schering-Plough Pty. Limited | Topical parasiticide formulations and methods of treatment |
AU2002952597A0 (en) * | 2002-11-11 | 2002-11-28 | Schering-Plough Pty. Limited | Topical parasiticide formulations and methods of treatment |
AU2003900505A0 (en) * | 2003-02-05 | 2003-02-20 | Jurox Pty Ltd | Anthelmintic composition |
-
2003
- 2003-07-12 GB GBGB0316377.1A patent/GB0316377D0/en not_active Ceased
-
2004
- 2004-07-12 GB GB0415541A patent/GB2403905B/en not_active Expired - Lifetime
- 2004-07-12 DK DK04743347.9T patent/DK1646425T3/da active
- 2004-07-12 KR KR1020067000779A patent/KR101095419B1/ko not_active IP Right Cessation
- 2004-07-12 PT PT04743347T patent/PT1646425E/pt unknown
- 2004-07-12 OA OA1200600008A patent/OA13188A/en unknown
- 2004-07-12 CN CN200480020006XA patent/CN1822880B/zh not_active Expired - Fee Related
- 2004-07-12 BR BRPI0412522-3A patent/BRPI0412522A/pt not_active IP Right Cessation
- 2004-07-12 PL PL04743347T patent/PL1646425T3/pl unknown
- 2004-07-12 SI SI200431947T patent/SI1646425T1/sl unknown
- 2004-07-12 EP EP10012261A patent/EP2286876A1/en not_active Withdrawn
- 2004-07-12 AU AU2004257450A patent/AU2004257450B2/en not_active Expired
- 2004-07-12 GE GEAP20049216A patent/GEP20094648B/en unknown
- 2004-07-12 WO PCT/GB2004/003006 patent/WO2005007241A1/en active Application Filing
- 2004-07-12 EA EA200600237A patent/EA009602B1/ru not_active IP Right Cessation
- 2004-07-12 ES ES04743347T patent/ES2390224T3/es not_active Expired - Lifetime
- 2004-07-12 NZ NZ544973A patent/NZ544973A/en not_active IP Right Cessation
- 2004-07-12 MX MXPA06000135A patent/MXPA06000135A/es active IP Right Grant
- 2004-07-12 CA CA2532199A patent/CA2532199C/en not_active Expired - Fee Related
- 2004-07-12 JP JP2006519991A patent/JP4677405B2/ja not_active Expired - Lifetime
- 2004-07-12 AP AP2006003506A patent/AP2956A/xx active
- 2004-07-12 EP EP04743347A patent/EP1646425B1/en not_active Expired - Lifetime
-
2006
- 2006-01-05 CR CR8174A patent/CR8174A/es unknown
- 2006-01-09 TN TNP2006000006A patent/TNSN06006A1/en unknown
- 2006-01-10 IL IL173057A patent/IL173057A/en not_active IP Right Cessation
- 2006-01-12 US US11/330,671 patent/US8993546B2/en active Active
- 2006-01-13 ZA ZA200600374A patent/ZA200600374B/en unknown
- 2006-02-10 EC EC2006006360A patent/ECSP066360A/es unknown
- 2006-02-10 NO NO20060676A patent/NO336181B1/no not_active IP Right Cessation
-
2007
- 2007-02-09 HK HK07101577.2A patent/HK1096621A1/xx not_active IP Right Cessation
-
2012
- 2012-09-10 HR HRP20120721TT patent/HRP20120721T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR8174A (es) | Composicion parasiticida | |
CY1107530T1 (el) | Παρασιτοκτονος συνθεση μακρας δρασης πepιεχουσα μια ενωση σαλικυλανιλιδιου, ενα πολυμepικο ειδος και τουλαχιστον μια αλλη αντιπαρασιτικη ενωση | |
CL2018001762A1 (es) | Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas. (divisional solicitud 201402087). | |
CR8464A (es) | Formulaciones topicas que comprenden un derivado de 1-n-arilpirazol y una formamidina | |
BRPI0418098A (pt) | formulações veterinárias não contendo produtos animais | |
IL176059A0 (en) | Active substance combinations having insecticidal properties | |
AR039537A1 (es) | Sistemas de cebo rodenticidas | |
AR057319A1 (es) | Composicion para la administracion topica y metodo para evitar o tratar infeccion o infestacion endoparasitica y ectoparasitica en un animal de sangre caliente | |
CY1111923T1 (el) | Παρασιτοκτονα σκευασματα | |
NO20016107L (no) | Mesalazin-kontrollert frigivelse orale farmasöytiske sammensetninger | |
GT201000160A (es) | Derivados de aminobenzamida como agentes útiles para el control de parásitos de animales | |
AR060132A1 (es) | Combinaciones de principios activos con propiedades insecticidas y acaricidas | |
ES2156603T3 (es) | Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina. | |
PA8541401A1 (es) | Empleo de etoxilatos de alcoholes grasos como favorecedores de la penetracion | |
ECSP056074A (es) | Composiciones y método para tratar las infecciones microbianas y parasitarias en el ganado y otros animales | |
CL2007001791A1 (es) | Combinacion fungicida que comprende (i) tebuconazol, (ii)azoxistrobina y (iii) fludioxonil, y opcionalmente (iv) uno o mas auxiliares de formulacion habituales; metodo para controlar o prevenir danos por patogenos fungicos | |
HRP20120097T1 (hr) | Aktivna tvar koja sadrži čvrsta oblikovana tijela za vanjsku uporabu protiv parazita na životinjama | |
ATE392889T1 (de) | Orale antimikrobielle pharmazeutische zusammensetzungen | |
AR044209A1 (es) | Composiciones farmaceuticas que comprenden epinastina para el tratamiento de enfermedades de la piel | |
PE20060908A1 (es) | Composicion antihelmintica | |
ATE303137T1 (de) | Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit | |
AR021690A1 (es) | Empleo de inhibidores del canal de ktq1 para la preparacion de un medicamento para el tratamiento de enfermedades, que son provocadas por helmintos yectoparasitos. | |
AR038853A1 (es) | Una composicion parasiticida inyectable | |
AR052867A1 (es) | Una composicion parasiticida | |
AR075428A1 (es) | Formulacion de doramectina en dosis elevada |